PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $308,000 | +8.8% | 99,587 | +0.0% | 0.00% | – |
Q4 2021 | $283,000 | -62.5% | 99,561 | -8.9% | 0.00% | – |
Q3 2021 | $754,000 | -26.3% | 109,269 | -1.9% | 0.00% | – |
Q2 2021 | $1,023,000 | -56.9% | 111,404 | -54.4% | 0.00% | -100.0% |
Q1 2021 | $2,376,000 | +63.6% | 244,367 | +72.8% | 0.00% | – |
Q4 2020 | $1,452,000 | +2.0% | 141,450 | +0.2% | 0.00% | -100.0% |
Q3 2020 | $1,424,000 | -69.7% | 141,183 | -68.7% | 0.00% | -50.0% |
Q2 2020 | $4,706,000 | +16.3% | 451,140 | -5.9% | 0.00% | 0.0% |
Q1 2020 | $4,047,000 | -63.9% | 479,528 | -62.5% | 0.00% | -50.0% |
Q4 2019 | $11,202,000 | -10.5% | 1,280,288 | +10.2% | 0.00% | -20.0% |
Q3 2019 | $12,511,000 | +62.1% | 1,162,241 | +91.4% | 0.01% | +66.7% |
Q2 2019 | $7,716,000 | +207.2% | 607,125 | +5606.6% | 0.00% | -78.6% |
Q1 2015 | $2,512,000 | +44.4% | 10,639 | +15.7% | 0.01% | +40.0% |
Q4 2014 | $1,740,000 | -18.7% | 9,194 | +2.5% | 0.01% | -23.1% |
Q3 2014 | $2,139,000 | +35.8% | 8,967 | -40.7% | 0.01% | +44.4% |
Q1 2014 | $1,575,000 | +226.8% | 15,126 | +224.9% | 0.01% | +200.0% |
Q4 2013 | $482,000 | – | 4,655 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |